Background During the lockdown period associated with the coronavirus disease 2019 (COVID-19) pandemic, increased mortality rates among patients with COVID-19 have been reported. This study aimed to analyze the mortality rate of osteoporotic hip fractures in patients who were COVID-19-positive after the lockdown during the Omicron period.
Methods A retrospective study was performed with 194 patients who were aged 70 years or more and diagnosed with osteoporotic hip fracture. The patients were divided into two groups according to their COVID-19 diagnoses. Surgery was performed within 10 days of diagnosis. Age, sex, past medical history, time until surgery, postoperative complications, and the primary outcome of mortality rate at 30 and 90 days were analyzed.
Results Among the 194 patients, 13 and 181 were in the COVID-19-positive and negative group, respectively. The total, 30-day, and 90-day mortality rates in the control and COVID-positive group were 11% and 0% (P=0.368), 1.7% and 0% (P=1.000), and 5.0% and 0% (P=1.000), respectively. No significant differences were observed in age, sex, history, time to surgery, postoperative complications, or postoperative mortality. In 1:1 propensity score matching, the time to surgery was 5.34 days in patients who were COVID-19-positive, and 3.00 days in patients who were COVID-19 negative, with no statistical significance (P=0.09). Age, sex, medical history, postoperative complications, and postoperative mortality were not significantly different between the groups.
Conclusions Regardless of the COVID-19 diagnosis, surgical treatment without delay is believed to result in positive outcomes in older patients with osteoporotic hip fractures, as no significant differences in mortality rate and respiratory complications were observed between patients who were COVID-19-positive and those who were COVID-19 negative.
Citations
Citations to this article as recorded by
1. Epidemiological (secular) trends of pelvic and acetabular fractures (2006–2022) in South Korea using a nationwide cohort data over ages 50: is it osteoporosis related? Byung-Ho Yoon, Tae-Young Kim, HoeJeong Chung, Jaiyong Kim, Jihye Kim, Hoyeon Jang, Young-Kyun Lee Archives of Osteoporosis.2025;[Epub] CrossRef
2. A Multi-Center Prospective Study on Post-Vaccination Humoral Response to SARS-CoV-2 in Polish Long-Term Care Facility Residents: Associations with COVID-19 Clinical Course and Comorbidities Justyna Brodowicz, Piotr Heczko, Estera Jachowicz-Matczak, Mateusz Gajda, Katarzyna Gawlik, Dorota Pawlica-Gosiewska, Bogdan Solnica, Jadwiga Wójkowska-Mach Infectious Disease Reports.2025; 17(4): 89. CrossRef
Background The coronavirus disease 2019 (COVID-19) pandemic and the consequent social distancing period are thought to have influenced the incidence of osteoporotic fracture in various ways, but the exact changes have not yet been well elucidated. The purpose of this study was to investigate the impact of the COVID-19 pandemic on the incidence of osteoporotic fracture using a nationwide cohort.
Methods The monthly incidence rates of vertebral; hip; and non-vertebral, non-hip fractures were collected from a nationwide database of the Korean National Health Insurance Review and Assessment from July 2016 to June 2021. Segmented regression models were used to assess the change in levels and trends in the monthly incidence of osteoporotic fractures.
Results There was a step decrease in the incidence of vertebral fractures for both males (6.181 per 100,000, P=0.002) and females (19.299 per 100,000, P=0.006). However, there was a negative trend in the incidence of hip fracture among both males (-0.023 per 100,000 per month, P=0.023) and females (-0.032 per 100,000 per month, P=0.019). No impact of COVID-19-related social distancing was noted.
Conclusions In conclusion, during the early days of the COVID-19 pandemic, vertebral fracture incidence considerably decreased with the implementation of social distancing measures.
Citations
Citations to this article as recorded by
1. Trends of incidence and 1-year mortality of vertebral fractures in Korea using nationwide claims data Young-Kyun Lee, Jung-Wee Park, Tae-Young Kim, Jihye Kim, Hoyeon Jang, Jaiyong Kim, Yong-Chan Ha Archives of Osteoporosis.2025;[Epub] CrossRef
2. Global, regional, and national burden of vertebral fractures among women from 1990 to 2021: a systematic analysis based on the global burden of disease study Junpeng Liu, Xingchen Yao, Zhiheng Zhao, Xinglin Liu, Sheyang Xu, Bowen Lu, Xianglong Meng European Spine Journal.2025;[Epub] CrossRef
Osteoporosis does not take a break while Coronavirus disease 2019 (COVID-19) stunned and overtook everyone’s lives. Medical resources were immediately shifted, self-isolation and telemedicine were expanded, ambulatory care services such as bone densitometry and osteoporosis-centered clinics came to a near halt. Progress with fracture prevention has been challenged because osteoporotic fracture with low energy injury is more prevalent even though restriction of people’s movement. Thus we must re-engage with chronic bone health concerns and fracture prevention. This review discusses challenges in management of osteoporosis during the COVID-19 pandemic and reinforces the need to implementing recommendations concerning the importance of bone fragility care with at least those patients who are already treated with antiosteoporotic drugs maintaining their adherence to treatments.
Citations
Citations to this article as recorded by
1. “Build better bones”: development, launch, and future directions of a multilingual, user-centered website for osteoporosis management Daniel Pinto, Olivier Bruyère, Mitali Sharma, Sydney Blomme, Robert D. Blank, Bjoern Buehring, Bruno Muzzi Camargos, Roland Chapurlat, Thierry Chevalley, Elaine M. Dennison, Jean-François Kaux, Nancy E. Lane, Osvaldo Daniel Messina, René Rizzoli, Jorge Mo Osteoporosis International.2026;[Epub] CrossRef
2. Osteoporosis-Associated Mortality in Postmenopausal Women in the United States From 1999 to 2023: A CDC WONDER-Based Study Muhammad Shabir, Muhammad Yasin Khan, Muhammad Younas Khan, Murad Ali, Rahman Syed, Ameer Afzal Khan , Anfal Khan, Fazal Syed, Mohammad Idrees, Muhammad Tariq Cureus.2025;[Epub] CrossRef
3. Zoledronic acid: challenges and pitfalls amid rehabilitation in primary osteoporosis and beyond Alexandru Florin Florescu, Oana-Claudia Sima, Mihai Costăchescu, Mihaela Stanciu, Ligia Florina Popa, Claudiu Nistor, Mădălina Gabriela Iliescu, Mihai-Lucian Ciobica, Mara Carsote Balneo and PRM Research Journal.2024; 15(Vol.15, no): 704. CrossRef
4. Self-care during the COVID-19 pandemic: Development of a virtual educational booklet for postmenopausal women with osteoporosis Ana Cristina Lima Carvalho, Flávia de Araújo Gomes, Alana Vallessa Bernardo Silva, Marcelo Souza Araújo, Germana Medeiros Barbosa, Mariana Arias Avila, Marcelo Cardoso de Souza Journal of Bodywork and Movement Therapies.2023; 34: 74. CrossRef
5. Bridging the Gap: Pregnancy—And Lactation—Associated Osteoporosis Mara Carsote, Maria Roxana Turturea, Ana Valea, Cristian Buescu, Claudiu Nistor, Ionut Florin Turturea Diagnostics.2023; 13(9): 1615. CrossRef
6. IMPACT OF THE COVID-19 PANDEMIC ON FRAGILITY HIP FRACTURE MANAGEMENT AND MORTALITY RATE Tana Rattanakitkoson, Guntarat Chinvattanachot, Urawit Piyapromdee Journal of Southeast Asian Medical Research.2023; 7: e0155. CrossRef
7. A 2-year follow-up of a novel Fracture Liaison Service: can we reduce the mortality in elderly hip fracture patients? A prospective cohort study D. González-Quevedo, V. Pérez-del-Río, D. Moriel-Garceso, N. Fernández-Arroyabe, G. García-Meléndez, M. Montañez-Ruiz, M. Bravo-Bardají, D. García-de-Quevedo, I. Tamimi Osteoporosis International.2022; 33(8): 1695. CrossRef
8. Arthritis with osteoporosis crippled the elderly during Covid-19 pandemic: A silent killer? Gaurav Govil, Lavindra Tomar, Pawan Dhawan IP International Journal of Orthopaedic Rheumatology.2022; 8(1): 38. CrossRef
9. Dispensing anti-osteoporotic drugs changed during the COVID-19 pandemic Roland Kocijan, Theresa Stockinger, Judith Haschka, Berthold Reichardt, Heinrich Resch, Jochen Zwerina, Martina Behanova Bone.2022; 162: 116477. CrossRef
10. Osteoporosis in Patients With Respiratory Diseases Yue Ma, Shui Qiu, Renyi Zhou Frontiers in Physiology.2022;[Epub] CrossRef
11. Effects of COVID-19 confinement on the incidence and mortality of major osteoporotic fractures: an observational study in Catalonia, Spain Xavier Surís, Emili Vela, Montserrat Clèries, Esteve Llargués, Jordi Camins, Marta Larrosa Archives of Osteoporosis.2022;[Epub] CrossRef
First
Prev
